Factors Associated with Non-Adherence to Treatment Among Migrants with MDR-TB in Wuhan, China: A Cross-Sectional Study

References

• Jang JG, Chung JH. Diagnosis and treatment of multidrug-resistant tuberculosis. Yeungnam Univ J Med. 2020;37(4):277–285. doi:10.12701/yujm.2020.00626
   PubMedGoogle Scholar
• Uplekar M, Weil D, Lonnroth K, et al. WHO’s new end TB strategy. Lancet. 2015;385(9979):1799–1801. doi:10.1016/S0140-6736(15)60570-0
   PubMed Web of Science ®Google Scholar
• Khademi F, Sahebkar A. An updated systematic review and meta-analysis on Mycobacterium tuberculosis antibiotic resistance in Iran (2013–2020). Iran J Basic Med Sci. 2021;24(4):428–436. doi:10.22038/IJBMS.2021.48628.11161
   PubMed Web of Science ®Google Scholar
• Sultana ZZ, Hoque FU, Beyene J, et al. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):51. doi:10.1186/s12879-020-05749-2
   PubMed Web of Science ®Google Scholar
• Goyal V, Kadam V, Narang P, Singh V. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis. BMC Public Health. 2017;17(1):817. doi:10.1186/s12889-017-4779-5
   PubMed Web of Science ®Google Scholar
• Ding P, Li X, Jia Z, Lu Z. Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis. BMC Infect Dis. 2017;17(1):57. doi:10.1186/s12879-016-2151-5
   PubMedGoogle Scholar
• World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019. Available from https://www.who.int/tb/publications/2019/consolidated-guidelines-drug-resistant-TB-treatment/en/. Accessed July 25, 2022.
   Google Scholar
• Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology. 2018;23(7):656–673. doi:10.1111/resp.13304
   PubMed Web of Science ®Google Scholar
• Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–1567. doi:10.1111/jam.14478
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Available from http://www.who.int/chronic_conditions/adherencereport/en/. Accessed July 25, 2022.
   Google Scholar
• Broekmans JF, Migliori GB, Rieder HL, et al.; World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002;19(4):765–775. doi:10.1183/09031936.02.00261402
   PubMed Web of Science ®Google Scholar
• Woldesemayat EM. Tuberculosis in migrants is among the challenges of tuberculosis control in high-income countries. Risk Manag Healthc Policy. 2021;14:2965–2970. doi:10.2147/RMHP.S314777
   PubMed Web of Science ®Google Scholar
• Anderson LF, Tamne S, Watson JP, et al. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill. 2013;18(40):20601. doi:10.2807/1560-7917.es2013.18.40.20601
   PubMedGoogle Scholar
• Kawatsu L, Uchimura K, Ohkado A. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data. BMC Infect Dis. 2021;21(1):42. doi:10.1186/s12879-020-05712-1
   PubMed Web of Science ®Google Scholar
• Lai S, Farnham A, Ruktanonchai NW, Tatem AJ. Measuring mobility, disease connectivity and individual risk: a review of using mobile phone data and mHealth for travel medicine. J Travel Med. 2019;26(3):taz019. doi:10.1093/jtm/taz019
   PubMed Web of Science ®Google Scholar
• Nelson KN, Shah NS, Mathema B, et al. Spatial patterns of extensively drug-resistant tuberculosis transmission in KwaZulu-Natal, South Africa. J Infect Dis. 2018;218(12):1964–1973. Erratum in: J Infect Dis. (2019) 219(3):509. doi:10.1093/infdis/jiy394
   PubMed Web of Science ®Google Scholar
• Khan FU, Khan FU, Hayat K, et al. Impact of protracted displacement on delay in the diagnosis associated with treatment outcomes: a cross-sectional study in internally displaced tuberculosis patients of Pakistan. Int J Environ Res Public Health. 2021;18(22):11984. doi:10.3390/ijerph182211984
   PubMed Web of Science ®Google Scholar
• Abarca Tomás B, Pell C, Bueno Cavanillas A, Guillén Solvas J, Pool R, Roura M. Tuberculosis in migrant populations. A systematic review of the qualitative literature. PLoS One. 2013;8(12):e82440. doi:10.1371/journal.pone.0082440
   PubMed Web of Science ®Google Scholar
• Woodward A, Howard N, Wolffers I. Health and access to care for undocumented migrants living in the European Union: a scoping review. Health Policy Plan. 2014;29:818–830. doi:10.1093/heapol/czt061
   PubMed Web of Science ®Google Scholar
• Lin S, Melendez-Torres GJ. Systematic review of risk factors for nonadherence to TB treatment in immigrant populations. Trans R Soc Trop Med Hyg. 2016;110:268–280. doi:10.1093/trstmh/trw025
   PubMed Web of Science ®Google Scholar
• Long Q, Jiang WX, Zhang H, Cheng J, Tang SL, Wang WB. Multi-source financing for tuberculosis treatment in China: key issues and challenges. Infect Dis Poverty. 2021;10(1):17. doi:10.1186/s40249-021-00809-4
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao Y. Multidrug-resistant tuberculosis in rural China: lack of public awareness, unaffordable costs and poor clinical management. BMJ Case Rep. 2018;2018:bcr2018225794. doi:10.1136/bcr-2018-225794
   PubMedGoogle Scholar
• Zhang LX, Tu DH, An YS, Enarson DA. The impact of migrants on the epidemiology of tuberculosis in Beijing, China. Int J Tuberc Lung Dis. 2006;10(9):959–962.
   PubMed Web of Science ®Google Scholar
• Xing W, Zhang R, Jiang W, et al. Adherence to multidrug resistant tuberculosis treatment and case management in Chongqing, China - a mixed method research study. Infect Drug Resist. 2021;14:999–1012. doi:10.2147/IDR.S293583
   PubMed Web of Science ®Google Scholar
• Feng M, Xu Y, Zhang X, et al. Risk factors of multidrug-resistant tuberculosis in China: a meta-analysis. Public Health Nurs. 2019;36(3):257–269. doi:10.1111/phn.12582
   PubMed Web of Science ®Google Scholar
• Zhou C, Chu J, Liu J, et al. Adherence to tuberculosis treatment among migrant pulmonary tuberculosis patients in Shandong, China: a quantitative survey study. PLoS One. 2012;7(12):e52334. doi:10.1371/journal.pone.0052334
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhao M, Wang Y, et al. Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study. BMC Public Health. 2015;15:474. doi:10.1186/s12889-015-1789-z
   PubMed Web of Science ®Google Scholar
• Mao W, Jiang W, Hamilton C, et al. Over- and under-treatment of TB patients in Eastern China: an analysis based on health insurance claims data. Trop Med Int Health. 2019;24(9):1078–1087. doi:10.1111/tmi.13287
   PubMed Web of Science ®Google Scholar
• Bastos ML, Cosme LB, Fregona G, et al. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis. BMC Infect Dis. 2017;17(1):718. doi:10.1186/s12879-017-2810-1
   PubMed Web of Science ®Google Scholar
• Liu XH, Han LM, Yuan B. Does the conversion of household registration actually improve the happiness of migrant workers in China? Int J Environ Res Public Health. 2020;17(8):2661. doi:10.3390/ijerph17082661
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang Z, Chen H, et al. The association between household financial burden and patient mobility and their impact on loss to follow-up among multidrug-resistant tuberculosis patients in Guizhou, China. Risk Manag Healthc Policy. 2023;16:909–919. doi:10.2147/RMHP.S400667
   PubMed Web of Science ®Google Scholar
• Pedrazzoli D, Carter DJ, Borghi J, Laokri S, Boccia D, Houben RM. Does Ghana’s National Health Insurance Scheme provide financial protection to tuberculosis patients and their households? Soc Sci Med. 2021;277:113875. doi:10.1016/j.socscimed.2021.113875
   PubMed Web of Science ®Google Scholar
• Koo HK, Min J, Kim HW, et al. Prediction of treatment failure and compliance in patients with tuberculosis. BMC Infect Dis. 2020;20(1):622. doi:10.1186/s12879-020-05350-7
   PubMed Web of Science ®Google Scholar
• Tanser F, Bärnighausen T, Vandormael A, Dobra A. HIV treatment cascade in migrants and mobile populations. Curr Opin HIV AIDS. 2015;10(6):430–438. doi:10.1097/COH.0000000000000192
   PubMed Web of Science ®Google Scholar
• Chen X, Wang W, Hua Q, et al. Persistent discrimination of TB in Southeastern China: results from Four Repeated Population-Based Surveys During the Period of 2006–2018. Risk Manag Healthc Policy. 2021;14:2333–2344. doi:10.2147/RMHP.S311869
   PubMed Web of Science ®Google Scholar
• National Health Commission. 2016 report on the Development of China’s Floating Population. Beijing: National Health Commission; 2016. Available from http://www.nhc.gov.cn/rkjcyjtfzs/pgzdt/201610/57cf8a2bbafe4b4d9a7be10d10ae5ecf.shtml. Accessed March 1, 2024.
   Google Scholar
• Lu CW, Lee YH, Pan YH, et al. Tuberculosis among migrant workers in Taiwan. Global Health. 2019;15(1):18. doi:10.1186/s12992-019-0461-2
   PubMedGoogle Scholar
• Luo Y, Guo C, Wang Y, Zheng X. Trends and challenges for population health and migration - China, 2015–2050. China CDC Wkly. 2020;2(28):520–524. doi:10.46234/ccdcw2020.141
   PubMedGoogle Scholar
• Tian Y, Chen Y, Zhou M, Zhao S. Institutional design and incentives for migrant workers to participate in social insurance in China: evidence from a policy experiment in Chengdu City. Front Public Health. 2021;9:736340. doi:10.3389/fpubh.2021.736340
   PubMed Web of Science ®Google Scholar
• Chan KW, Wong MH, Hui CL, Lee EH, Chang WC, Chen EY. Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers. Soc Psychiatry Psychiatr Epidemiol. 2015;50(2):307–315. doi:10.1007/s00127-014-0930-0
   PubMed Web of Science ®Google Scholar
• Zhao Y, Kang B, Liu Y, et al. Health insurance coverage and its impact on medical cost: observations from the floating population in China. PLoS One. 2014;9(11):e111555. doi:10.1371/journal.pone.0111555
   PubMed Web of Science ®Google Scholar
• Castelli F. Drivers of migration: why do people move? J Travel Med. 2018;25:tay040. doi:10.1093/jtm/tay040
   Web of Science ®Google Scholar
• Mou J, Cheng J, Zhang D, Jiang H, Lin L, Griffiths SM. Health care utilisation amongst Shenzhen migrant workers: does being insured make a difference? BMC Health Serv Res. 2009;9:214. doi:10.1186/1472-6963-9-214
   PubMed Web of Science ®Google Scholar
• Wang S, Liu A, Guo W. Public and commercial medical insurance enrollment rates of rural-to-urban migrants in China. Front Public Health. 2021;9:749330. doi:10.3389/fpubh.2021.749330
   PubMed Web of Science ®Google Scholar
• GBD Tuberculosis Collaborators. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis. 2018;18(12):1329–1349. doi:10.1016/S1473-3099(18)30625-X
   PubMed Web of Science ®Google Scholar
• Deshmukh RD, Dhande DJ, Sachdeva KS, Sreenivas AN, Kumar AMV, Parmar M. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian J Tuberc. 2018;65(1):41–47. doi:10.1016/j.ijtb.2017.05.003
   PubMedGoogle Scholar